Stay updated on Tralokinumab+Corticosteroids in Severe Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Tralokinumab+Corticosteroids in Severe Atopic Dermatitis Clinical Trial page.

Latest updates to the Tralokinumab+Corticosteroids in Severe Atopic Dermatitis Clinical Trial page
- Check5 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.1%
- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check41 days agoChange DetectedThe page has undergone significant content changes regarding a clinical study on HER2+ Metastatic Breast Cancer, with the removal of detailed study descriptions and criteria, while a new identifier and revision number have been added.SummaryDifference6%
- Check49 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check66 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check95 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.6%
Stay in the know with updates to Tralokinumab+Corticosteroids in Severe Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tralokinumab+Corticosteroids in Severe Atopic Dermatitis Clinical Trial page.